712P CAPT: A multicenter randomized controlled trial of perioperative versus postoperative camrelizumab plus apatinib for resectable hepatocellular carcinoma
Xizhuang Bai, Y. Chen, X. Zhang, Fan Zhang, Xing Liang, Chunyun ZHANG, Xuming Wang, Bin Lu, Shian Yu, T. Liang
Topics & Concepts
MedicinePerioperativeApatinibClinical endpointSurgeryHepatocellular carcinomaNeoadjuvant therapyInternal medicineResponse Evaluation Criteria in Solid TumorsAdjuvant therapyAdjuvantRandomized controlled trialOncologyProgressive diseaseChemotherapyCancerBreast cancerHepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and StudiesCancer Immunotherapy and Biomarkers